
|Articles|January 1, 2012
- Pharmaceutical Executive-01-01-2012
- Volume 0
- Issue 0
Pharmaceutical Executive Digital Edition - January 2012
Industry Forecast 2012 : Bridging the Divide
Advertisement
Articles in this issue
over 14 years ago
Hungary Report: Redefining Sustainabilityover 14 years ago
Emerging Markets: Bridging the Cancer Divideover 14 years ago
Financing R&D Through a Range of Consumer Productsover 14 years ago
New Year, New Issuesover 14 years ago
Innovation: Why is Pharma Scared to Death?over 14 years ago
Top Medical Innovations 2012over 14 years ago
Essential Questions for Essential Benefitsover 14 years ago
Copay Cards and Coupons: Letting the Facts Get in the Wayover 14 years ago
Pharma 2012: Hard Times Before the Harvestover 14 years ago
Here's to a Happier New Year?Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
FDA Approves Otsuka’s First-In-Class Simtriyo for Adults & Pediatric Patients
2
argenx Acquires Forte Biosciences for $2.2 Billion
3
Where the True Bottlenecks Exist at FDA for Clinical Trials
4
Moving From Symptom Management to Disease Modification in Parkinson’s Research: Q&A with Dr. Jan Stoehr
5




